Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
UNH
|
Timothy Patrick Flynn
Director |
BUY
Grant, award, or other acquisition
|
Direct | 336 Added 9.59% |
-
|
Apr 01
2019 |
UNH
|
Michele J Hooper
Director |
BUY
Grant, award, or other acquisition
|
Direct | 209 Added 0.62% |
-
|
Apr 01
2019 |
UNH
|
Frederick William Mcnabb Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 336 Added 18.82% |
-
|
Apr 01
2019 |
UNH
|
Rice Valerie Md Montgomery
Director |
BUY
Grant, award, or other acquisition
|
Direct | 209 Added 13.71% |
-
|
Apr 01
2019 |
UNH
|
John H Noseworthy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 180 Added 50.0% |
-
|
Apr 01
2019 |
UNH
|
Glenn M Renwick
Director |
BUY
Grant, award, or other acquisition
|
Direct | 362 Added 0.44% |
-
|
Apr 01
2019 |
UNH
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct | 209 Added 0.33% |
-
|
Apr 01
2019 |
ACN
|
Johan Deblaere
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 3.91% |
$527,490
$175.83 p/Share
|
Apr 01
2019 |
ACN
|
Ellyn Shook
Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct | 2,343 Reduced 6.57% |
$412,509
$176.06 p/Share
|
Apr 01
2019 |
ACN
|
Noordende Alexander M Van 'T
Group Chief Exec-Products |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 3.11% |
$703,960
$175.99 p/Share
|
Apr 01
2019 |
ACN
|
David Rowland
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 6,182 Reduced 16.23% |
$1,085,868
$175.65 p/Share
|
Apr 01
2019 |
EA
|
Chris Bruzzo
Chief Experience Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 7.84% |
$309,000
$103.0 p/Share
|
Apr 01
2019 |
EA
|
Laura Miele
President of EA Entertainment |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 24.47% |
$128,687
$102.95 p/Share
|
Apr 01
2019 |
EA
|
Andrew Wilson
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 100.0% |
$2,062,600
$103.13 p/Share
|
Apr 01
2019 |
EA
|
Andrew Wilson
Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 50.0% |
$525,000
$26.25 p/Share
|
Apr 01
2019 |
EA
|
Andrew Wilson
Chairman & CEO |
SELL
Open market or private sale
|
Indirect | 9,000 Reduced 2.8% |
$924,480
$102.72 p/Share
|
Apr 01
2019 |
GOOG
|
Ann Mather
Director |
SELL
Open market or private sale
|
Direct | 39 Reduced 2.12% |
$46,098
$1182.0 p/Share
|
Apr 01
2019 |
SNX
|
Marshall Witt
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 600 Reduced 3.39% |
$57,864
$96.44 p/Share
|
Apr 01
2019 |
SPOK
|
Nathaniel Blair Butterfield
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 1,101 Added 4.97% |
$14,996
$13.62 p/Share
|
Apr 01
2019 |
SPOK
|
Stacia Hylton
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,101 Added 7.58% |
$14,996
$13.62 p/Share
|
Apr 01
2019 |
SPOK
|
Brian Oreilly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,101 Added 2.57% |
$14,996
$13.62 p/Share
|
Apr 01
2019 |
SPOK
|
Matthew Oristano
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,285 Added 3.42% |
$17,502
$13.62 p/Share
|
Apr 01
2019 |
SPOK
|
Todd J Stein |
BUY
Grant, award, or other acquisition
|
Indirect | 0 Added 0.0% |
-
|
Apr 01
2019 |
SPOK
|
Todd J Stein |
BUY
Grant, award, or other acquisition
|
Direct | 1,101 Added 27.03% |
$14,996
$13.62 p/Share
|
Apr 01
2019 |
SPOK
|
Samme L Thompson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,101 Added 2.52% |
$14,996
$13.62 p/Share
|
Apr 01
2019 |
SPOK
|
Royce Yudkoff
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,101 Added 2.46% |
$14,996
$13.62 p/Share
|
Apr 01
2019 |
VC
|
Markus J Schupfner
Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 116 Reduced 9.42% |
$8,154
$70.29 p/Share
|
Apr 01
2019 |
VC
|
Markus J Schupfner
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 225 Added 15.44% |
-
|
Apr 01
2019 |
NTRS
|
Linda Bynoe
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8 Added 0.04% |
$742
$92.7 p/Share
|
Apr 01
2019 |
NTRS
|
Dean M Harrison
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8 Added 0.11% |
$742
$92.7 p/Share
|
Apr 01
2019 |
NTRS
|
Becerra Jose Luis Prado
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8 Added 0.08% |
$742
$92.7 p/Share
|
Apr 01
2019 |
NTRS
|
Thomas E Richards
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8 Added 0.12% |
$742
$92.7 p/Share
|
Apr 01
2019 |
NTRS
|
Donald Thompson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9 Added 0.16% |
$834
$92.7 p/Share
|
Apr 01
2019 |
NTRS
|
Charles A Tribbett
Director |
BUY
Grant, award, or other acquisition
|
Direct | 8 Added 0.04% |
$742
$92.7 p/Share
|
Apr 01
2019 |
PFG
|
Julia M Lawler |
BUY
Open market or private sale
|
Direct | 1,000 Added 1.67% |
$50,740
$50.74 p/Share
|
Apr 01
2019 |
MKL
|
Steven A Markel
Director |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.1% |
$100,000
$1000.0 p/Share
|
Apr 01
2019 |
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 116,909 Reduced 2.16% |
$111,064
$0.95 p/Share
|
Apr 01
2019 |
ALRN
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,610 Reduced 0.98% |
$39,159
$1.9 p/Share
|
Apr 01
2019 |
ENPH
|
David A Ranhoff
EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 2,110 Reduced 0.25% |
$19,306
$9.15 p/Share
|
Apr 01
2019 |
BALY
|
Chatham Asset Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 65,000 Added 1.1% |
$2,014,350
$30.99 p/Share
|
Apr 01
2019 |
FHI
|
Michael J Farrell |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 7.29% |
$88,770
$29.59 p/Share
|
Apr 01
2019 |
FHI
|
Michael J Farrell |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 6.8% |
$70,680
$23.56 p/Share
|
Apr 01
2019 |
EVRI
|
Michael D Rumbolz
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 507 Reduced 0.5% |
$5,237
$10.33 p/Share
|
Apr 01
2019 |
EVRI
|
Michael D Rumbolz
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 2,084 Added 2.01% |
-
|
Apr 01
2019 |
IBCP
|
William J Boer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 383 Added 1.3% |
$8,234
$21.5 p/Share
|
Apr 01
2019 |
IBCP
|
Christina Keller
Director |
BUY
Grant, award, or other acquisition
|
Direct | 348 Added 9.79% |
$7,482
$21.5 p/Share
|
Apr 01
2019 |
WOW
|
Crestview Partners Iii Gp, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 91,964 Added 0.31% |
$871,819
$9.48 p/Share
|
Apr 01
2019 |
ATIP
|
Joseph Francis Jordan
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 13,818 Added 4.97% |
-
|
Mar 31
2019 |
LYB
|
Robin W.T. Buchanan |
BUY
Open market or private purchase
|
Direct | 455 Added 0.94% |
$39,881
$87.65 p/Share
|
Mar 31
2019 |
LGMK
|
Michael D'Almada Remedios
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,497 Added 12.15% |
$20,022
$0.89 p/Share
|
Mar 31
2019 |